Table 4 Results on the regional prescribing objectives in primary health care units with or without drug information from the pharmaceutical industry.
Without drug information from the pharmaceutical industry (n = 4) | With drug information from the pharmaceutical industry (n = 17) | P-value* | |
|---|---|---|---|
Generic omeprazole of PPIs | 77 (73-89) | 77 (72-81) | 0.59 |
ACEIs of ACEIs and ARBs | 62 (52-72) | 59 (54-61) | 0.72 |
Generic simvastatin of statins | 84 (81-92) | 75 (71-80) | 0.016 |
SSRI of antidepressants | 77 (74-78) | 71 (69-74) | 0.020 |
Non-escitalopram of SSRIs | 96 (94-97) | 94 (91-96) | 0.21 |
Generic mirtazapin of mirtazapins | 84 (78-93) | 85 (77-91) | 0.86 |